Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer

BACKGROUND: Basal-like breast cancer (BLBC) exhibits worse pathological features than other breast cancer subtypes, and patients diagnosed with BLBC have short disease-free and overall survival times. Thus, the identification of novel biomarkers and therapeutic targets for BLBC is of upmost importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, O'Brien, Daniel, Zhang, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444471/
https://www.ncbi.nlm.nih.gov/pubmed/36071863
http://dx.doi.org/10.1155/2022/7078787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444471/
https://www.ncbi.nlm.nih.gov/pubmed/36071863
http://dx.doi.org/10.1155/2022/7078787

Ejemplares similares